Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.
N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615.
N Engl J Med. 2017.
PMID: 28121498
Free article.
Clinical Trial.